Status:
COMPLETED
Identification of Motor Symptoms Related to Parkinson's Disease Using Motion Tracking Sensors at Home
Lead Sponsor:
Satakunta Central Hospital
Collaborating Sponsors:
Tampere University of Technology
Conditions:
Parkinson Disease
Eligibility:
All Genders
30+ years
Brief Summary
Parkinson's disease (PD) is a chronic and progressive neurological movement disorder, meaning that symptoms continue and worsen over time. Nearly 10 million people worldwide are living with Parkinson'...
Eligibility Criteria
Inclusion
- (A) participants must be 30 years of age or older. (B) (for the Parkinson groups) diagnosed with PD (ICD-10 code G20) by a physician (neurologist or physician specializing in neurology). (C) They should be able to walk at least 20 steps unassisted (subjects are allowed to get help from assistive devices but not from other persons).
Exclusion
- (A) The subjects must not be receiving any deep brain stimulation (DBS) treatment while they are participating, but intraduodenal administration of levodopa (Duodopa®) or intradermal administration of apomorphine (Apogo® or Dacepton®) is accepted. (B) .Other extrapyramidal syndromes such as MSA (multiple system atrophy), PSP (progressive supranuclear palsy), CBD (corticobasal degeneration), LBD (Lewy body dementia) or dopamine antagonist drug (such as antipsychotic drug, metoclopramide) induced Parkinsonism will be excluded.
Key Trial Info
Start Date :
March 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT03366558
Start Date
March 27 2018
End Date
December 31 2019
Last Update
November 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Satakunta Central Hospital, Unit of Neurology
Pori, Finland